Madrigal Pharmaceuticals (MDGL) Total Non-Current Liabilities (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) recorded Total Non-Current Liabilities of $346.72 million in Q2 2026, up 182.1% from $122.9 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Madrigal Pharmaceuticals reported Total Non-Current Liabilities of $346.61 million, up 192.3% from FY2024.
- Annual Total Non-Current Liabilities has increased for three straight years, with a five-year compound annual growth rate of 274.9% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $118.59 million in FY2024 (+1.6%), $116.67 million in FY2023 (+136.7%), $49.29 million in FY2022 and $387,000 in FY2021 (-17.3%).
- The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2010.
- On a year-over-year basis, Total Non-Current Liabilities has increased for 13 consecutive quarters, with growth averaging 95.9% over the last eight quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 192.3% in Q4 2025, against a decline of 26.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $345.61 million (Q1 2026), $346.61 million (Q4 2025) and $345.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Madrigal Pharmaceuticals | 13.33 Bn | 9.58 Bn | - | 346.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 346.72 Mn |
| Mar 31, 2026 | 345.61 Mn |
| Dec 31, 2025 | 346.61 Mn |
| Sep 30, 2025 | 345.32 Mn |
| Jun 30, 2025 | 122.90 Mn |
| Mar 31, 2025 | 118.76 Mn |
| Dec 31, 2024 | 118.59 Mn |
| Sep 30, 2024 | 118.26 Mn |
| Jun 30, 2024 | 117.51 Mn |
| Mar 31, 2024 | 117.18 Mn |
| Dec 31, 2023 | 116.67 Mn |
| Sep 30, 2023 | 116.05 Mn |
| Jun 30, 2023 | 99.25 Mn |
| Mar 31, 2023 | 83.97 Mn |
| Dec 31, 2022 | 49.29 Mn |
| Sep 30, 2022 | 49.05 Mn |
| Jun 30, 2022 | 48.85 Mn |
| Mar 31, 2022 | 283,000.00 |
| Dec 31, 2021 | 387,000.00 |
| Sep 30, 2021 | 491,000.00 |
API Access
Madrigal Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();